In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation

Anesthesiology

Volumn 88, Issue 2, 1998, Pages 362-370

  Aoki, Hiroshl ^a   Mizobe, Toshiki ^a   Nozuchi, Shinji ^a   Hiramatsu, Noriko ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Calcium ions; Fluorescence, fura 2; High performance liquid chromatography; Intravenous anesthetics; Triglyceride

Indexed keywords

ADENOSINE TRIPHOSPHATE; ENFLURANE; HALOTHANE; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; LIPID EMULSION; MUSCLE RELAXANT AGENT; NITROUS OXIDE; OPIATE AGONIST; PROPOFOL; THROMBIN; TRIACYLGLYCEROL;

ARTICLE; BLEEDING; BLEEDING TIME; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLUORESCENCE; HEMOSTASIS; HUMAN; HUMAN TISSUE; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PAIN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031892619     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199802000-00015     Document Type: Article

References (39)

1. Ueda I: The effects of volatile general anesthetics on adenosine diphosphate-induced platelet aggregation. ANESTHESIOLOGY 1971; 34:405-8
2. Bjoraker DG: Failure of clinical concentrations of halothane to block adenosine diphosphate-induced platelet aggregation in vitro. Br J Anaesth 1979; 51:187-91
3. Dalsgaard-Nielsen J, Gormsen J: Effects of halothane on platelet function. Thromb Haemost 1980; 44:143-5
4. Walter F, Vulliemoz Y, Verosky M, Triner L: Effects of halothane on the cyclic 3′,5′-adenosine monophosphate enzyme system in human platelets. Anesth Analg 1980; 59:856-61
5. Kohro S, Yamakage M: Direct inhibitory mechanisms of halo- thane on human platelet aggregation. ANESTHESIOLOGY 1996; 85:96-106
6. Gibbs NM: The effects of anaesthetic agents on platelet function. Anaesth Intens Care 1991; 19:495-520
7. Fauss BG, Meadows JC, Bruni CY, Qureshi GD: The in vitro and in vivo effects of isoflurane and nitrous oxide on platelet aggregation. Anesth Analg 1986; 65:1170-4
8. Biaise GA, Parent M, Laurin S, Omri A, Reader TA, Moutquin JM: Platelet-induced vasomotion of isolated canine coronary artery in the presence of halothane or isoflurane. J Cardiothorac Vasc Anesth 1994; 8:175-81
9. Gotta AW, Gould P, Sullivan CA, Goldiner PL: The effect of enflurane and fentanyl anaesthesia on human platelet aggregation in vivo. Can Anaesth Soc J 1980; 27:319-22
10. Nygard E, Naesh O, Hindberg I, Valentin N: Effect of nitrous oxide and volatile anaesthetics on platelet function in man. Acta Anaesthesiol Scand 1994; 38:40-2
11. Smith I, White PF, Nathanson M, Gouldson R: Propofol. An update on its clinical use. ANESTHESIOLOGY 1994; 81:1005-43
12. Hansen E, Gartner KH, Gloßner M, Kutz N, Schuster A, Hoffman A: Der Einfluss von Propofol (Disoprivan®) auf die Funktion von Thrombozyten. Fortschritte der Anaesthesiol Notfallmedizin Intens 1992; 6:15-21
13. Wallis CB, Williams DR, McLaren M, Belch JJF, Macrae WA: Does propofol anaesthesia affect platelet aggregation? [Abstract A268]. Br J Anaesth 1995; 74(suppl 1):82
14. Türkan H, Süer AH, Beyan C, Grüzeldemir ME, Yalcin A: Effects of propofol on platelet aggregation [Abstract 267]. Br J Anaesth 1995; 74(suppl 1):81
15. Glen JB, Hunter SC, Blackburn TP, Wood P: Interaction studies and other investigations of the pharmacology of propofol ('Diprivan®'). Postgrad Med J 1985; 61 (suppl 3):7-14
16. Aviram M, Deckelbaum RJ: Intralipid infusion into humans reduces in vitro platelet aggregation and alters platelet lipid composition. Metabolism 1989; 38:343-7
17. Jarnvig IL, Naesh O, Hindberg I, Behnke O, Bregengaad C, Wilhjelm B: Platelet responses to intravenous infusion of Intralipid® in healthy volunteers. Am J Clin Nutr 1990; 52:628-31
18. Campbell AN, Freedman MH, Pencharz PB, Zlotkin SH: Bleeding disorder from the 'fat overload' syndrome. J Parenter Enter Nutr 1984; 8:447-9
19. Hayek T, Fuhrman B, Levy Y, Aviram M, Brook JG: Intralipid infusion in patients with familial hypercholesterolemia. Effect of serum and plasma lipoproteins on platelet aggregation and on macrophage cholesterol metabolism. Atherosclerosis 1990; 81:61-9
20. Born GVR, Cross MJ: The aggregation of blood platelets. J Physiol 1963; 168:178-95
21. Burnham WR, Heptinstall S, Cockbill SR, Harrison S: Blood platelet behavior during infusion of Intralipid-based intravenous feeding mixture. Postgrad Med J 1982; 58:152-5
22. Pavan I, Buglione E, Massiccio M: Monitoring propofol serum levels by rapid and sensitive reversed-phase high-performance liquid chromatography during prolonged sedation in ICU patients. J Chromatogr Sci 1992; 30:164-6
23. Gottardis M, Khünl-Brady KS, Koller W. Slgl G, Hackl JM: Effect of prolonged sedation with propofol on serum triglyceride and cholesterol concentrations. Br J Anaesth 1989; 62:393-6
24. Heinrichs W, Tranova I, Dick W: Sedation with propofol during post-operative artificial ventilation. J Drug Dev 1989; 2(suppl 2):53-4
25. Mertes N, Thülig B, Zander J, Schöppner H: Long-term sedation with continuous infusion of propofol in ventilated intensive care patients: preliminary experiences over 120 hours in six patients. J Drug Dev 1989; 2(suppl 2):77-8
26. Spayd RW, Bruschi B, Burdick BA, Dappen GM, Eikenberry JN, Esders TW, Figueras J, Goodhue CT, LaRossa DD, Nelson RW, Wu TW: Multilayer film elements for clinical analysis: Applications to representative chemical determinations. Clin Chem 1978; 24:1343-50
27. Jensen AG, Lindroth M, Sjölander A, Eintrei C: Propofol induces changes in the cystosolic free calcium concentration and the cytoskeletal organization of cultured human glial cells and primary embryonic rat brain cells. ANESTHESIOLOGY 1994; 81:1220-9
28. Lagerde M,Bryon PA, Guichardant M, Dechavanne M: A simple and efficient method for platelet isolation from their plasma. Thrombos Res 1980; 17:581-8
29. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260:3440-50
30. Himpens B, Somlyo A: Free-calcium and force transients during depolarization and pharmacomechanical coupling in guinea-pig smooth muscle. J Physiol 1988; 395:507-30
31. Sato K, Ozaki H, Karaki H: Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2. J Pharmacol Exp Ther 1988; 246:294-300
32. 2+ in individual small cells using fluorescence microscopy with dual excitation wavelength. Cell Calcium 1985; 6:145-57
33. Merritt JE, Jacob R, Hallam TJ: Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 1989; 264:1522-7
34. Hallam TJ, Rink TJ: Agonist stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett 1985; 186:175-9
35. Yamamoto N, Watanabe H, Kakizawa H, Hirano M, Kobayashi A, Ohno R: A study on thapsigargin-induced calcium ion and cation influx pathways in vascular endothelial cells. Biochem Biophys Acta 1995; 1266:157-62
36. Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS: Pharmacokinetics of propofol (Diprivan) in elderly patients. Br J Anaesth 1988; 60:146-50
37. Macmillan DC, Sim AK: A comparative study of platelet aggregation in man and laboratory animals. Thrombos Diathes Haemorrh (Stuttg) 1970; 24:385-94
38. 2 formation on close contact of human platelets in media with a low concentration of ionized calcium. Blood 1987; 70:647-51
39. 2+ thresholds and Ca-independent activation for shapechange and secretion. FEBS Lett 1982; 148:21-6